HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$0.49
Day range
$0.48 - $0.54
Year range
$0.40 - $5.85
Market cap
43.05M USD
Avg Volume
2.93M
P/E ratio
1.42
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 38.09M | 43.17% |
Operating expense | 20.41M | -24.98% |
Net income | 18.88M | 2,155.20% |
Net profit margin | 49.55 | 1,473.02% |
Earnings per share | 0.23 | 2,200.00% |
EBITDA | 18.09M | 15,176.67% |
Effective tax rate | 0.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.62M | -42.34% |
Total assets | 120.53M | -40.27% |
Total liabilities | 120.99M | -51.46% |
Total equity | -456.00K | — |
Shares outstanding | 80.10M | — |
Price to book | -49.46 | — |
Return on assets | 34.06% | — |
Return on capital | -2,251.53% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 18.88M | 2,155.20% |
Cash from operations | -19.91M | 9.36% |
Cash from investing | 15.14M | 17.64% |
Cash from financing | 2.25M | 821.72% |
Net change in cash | -2.52M | 71.49% |
Free cash flow | -20.42M | -303.17% |
About
Founded
2008
Headquarters
Website
Employees
120
